Saturday, January 25, 2020
Volume:
36
Issue:
1
Abstract:
As the ratifications of the U.S.-Mexico-Canada Agreement (USMCA) continue, professionals are focusing on the enforcement cooperation improvements in intellectual property and environmental law. On January 16, 2020, the U.S. Senate approved the agreement by a vote of 89 to 10. The month before, the House approved the agreement by a similarly wide margin, after months of negotiations between Democrats and the White House, which produced pro-labor revisions and jettisoned drug-exclusivity provisions the pharmaceutical industry sought.[1]